Skip to main content
The BMJ logoLink to The BMJ
letter
. 1990 Mar 24;300(6727):814. doi: 10.1136/bmj.300.6727.814

HIV infection and tuberculosis.

R Zangerle, P Fritsch, D Fuchs, H Wachter
PMCID: PMC1662534  PMID: 2322750

Full text

PDF

Page 814

814

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fuchs D., Hausen A., Reibnegger G., Werner E. R., Dierich M. P., Wachter H. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol Today. 1988 May;9(5):150–155. doi: 10.1016/0167-5699(88)91203-0. [DOI] [PubMed] [Google Scholar]
  2. Handwerger S., Mildvan D., Senie R., McKinley F. W. Tuberculosis and the acquired immunodeficiency syndrome at a New York City hospital: 1978-1985. Chest. 1987 Feb;91(2):176–180. doi: 10.1378/chest.91.2.176. [DOI] [PubMed] [Google Scholar]
  3. Selwyn P. A., Hartel D., Lewis V. A., Schoenbaum E. E., Vermund S. H., Klein R. S., Walker A. T., Friedland G. H. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989 Mar 2;320(9):545–550. doi: 10.1056/NEJM198903023200901. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES